The Administrative Core will be essential for success of the U19 programs proposed in this application. The goals of the core will be to provide administrative oversight and financial guidance and support. It will ensure patient safety and confidentiality, as well as maximize the coordination and scientific progress of all the projects. The core will establish an External Advisory Board and facilitate integration of all the projects. In addition, it will interface with the administrative, clinical and scientific resources of the Lowance Center for Human Immunology to facilitate patient recruitment, personnel training, sample collection, data acquisition, storage and management. It will also ensure coordination of internal and external operations of the Emory University Autoimmunity Center of Excellence (ACE) and its communication with the ACE Steering Committee. The Core will also ensure the education of all investigators and the implementation of all necessary protocols and safeguards required for patient safety and confidentiality. These goals will be achieved through the following Specific Aims:
Aim1) To provide administrative oversight and financial guidance and support to all components and investigators of the ACE;
Aim 2) To ensure patient safety and confidentiality;
Aim 3) To maximize the coordination and scientific progress of all projects;
Aim 4) To establish an External Advisory Board for the Emory ACE U19;
and Aim 5) To facilitate the internal and external integration of the Emory ACE U19. As designed, the core will have tremendous impact in maintaining the integrity of the U19 and facilitating internal and external integration. In all, it will be an essential tool to achieve our scientific and collaborative goals.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
2U19AI110483-06
Application #
9731110
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2019-05-01
Budget End
2020-04-30
Support Year
6
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Emory University
Department
Type
DUNS #
066469933
City
Atlanta
State
GA
Country
United States
Zip Code
30322
St Clair, E William; Baer, Alan N; Wei, Chungwen et al. (2018) Clinical Efficacy and Safety of Baminercept, a Lymphotoxin ? Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results From a Phase II Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis Rheumatol 70:1470-1480
Tipton, Christopher M; Hom, Jennifer R; Fucile, Christopher F et al. (2018) Understanding B-cell activation and autoantibody repertoire selection in systemic lupus erythematosus: A B-cell immunomics approach. Immunol Rev 284:120-131
Putterman, Chaim; Pisetsky, David S; Petri, Michelle et al. (2018) The SLE-key test serological signature: new insights into the course of lupus. Rheumatology (Oxford) 57:1632-1640
Upadhyay, Amit A; Kauffman, Robert C; Wolabaugh, Amber N et al. (2018) BALDR: a computational pipeline for paired heavy and light chain immunoglobulin reconstruction in single-cell RNA-seq data. Genome Med 10:20
Jenks, Scott A; Cashman, Kevin S; Zumaquero, Esther et al. (2018) Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus. Immunity 49:725-739.e6
Hamilton, Jennie A; Wu, Qi; Yang, PingAr et al. (2018) Cutting Edge: Intracellular IFN-? and Distinct Type I IFN Expression Patterns in Circulating Systemic Lupus Erythematosus B Cells. J Immunol 201:2203-2208
Barwick, Benjamin G; Scharer, Christopher D; Martinez, Ryan J et al. (2018) B cell activation and plasma cell differentiation are inhibited by de novo DNA methylation. Nat Commun 9:1900
Asare, A; Kanaparthi, S; Lim, N et al. (2017) B Cell Receptor Genes Associated With Tolerance Identify a Cohort of Immunosuppressed Patients With Improved Renal Allograft Graft Function. Am J Transplant 17:2627-2639
Fortner, Karen A; Bond, Jeffrey P; Austin, James W et al. (2017) The molecular signature of murine T cell homeostatic proliferation reveals both inflammatory and immune inhibition patterns. J Autoimmun 82:47-61
Sanz, Iñaki (2017) New Perspectives in Rheumatology: May You Live in Interesting Times: Challenges and Opportunities in Lupus Research. Arthritis Rheumatol 69:1552-1559

Showing the most recent 10 out of 33 publications